The Closing the Gap project began by collecting data on the practices' diabetes-related procedures and patients. ... The overwhelming response led to its reprinting for phase II of the Diabetes Initiative.
The prospective InterAct case-cohort study conducted in 26 centers in eight European countries, is investigating how genetics and lifestyle interact to affect diabetes risk. ... Waist circumference is just as important as other risk factors for diabetes
This regulatory update covers dapaglifozin (Farxiga) a sodium-glucose co-transporter 2 inhibitor, to treat diabetes, and umeclidinium and vilanterol inhalation (Anoro Ellipta) for maintenance of chronic obstructive pulmonary disease. ... It should not be
31, 2015. Canaglifozin (Invokana) tablets, to improve glycemic control in adults with type 2 diabetes, along with diet and exercise. ... It should not be used in patients with type 1 diabetes, diabetic ketoacidosis, severe renal impairment or end-stage
QD: News Every Day--Teens with type 2 diabetes likely to need combination therapy sooner. ... A majority of teenagers with type 2 diabetes may require combination treatment or insulin therapy within a few years of diagnosis, researchers concluded.
The FDA continues to investigate and has not determined whether the diabetes drug increases the risk of leg and foot amputations.
University of California-San Diego psychologist whose work focuses on patient self-management in diabetes. ... Glaseroff's patient had her diabetes under better control and, perhaps more importantly, was feeling much more positive about herself.
For example, continuous monitoring of patients with diabetes produces better outcomes, he said. ... At Partners, Dr. Kvedar said the focus is on using connected health to manage chronic diseases, such as hypertension, diabetes, and obesity.
Insulin degludec injection (Tresiba) and insulin degludec/insulin aspart injection (Ryzodeg 70/30) to improve glucose control in adults with diabetes. ... The former agent, a long-acting insulin analog for both type 1 and 2 diabetes, is subcutaneously
He also has type 2 diabetes mellitus that is treated with glyburide and metformin. ... This patient is male, obese and has diabetes mellitus, all of which are risk factors for DISH.